AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19033823
Drug: Intrabrachial Lys‐[Leu8]‐des‐Arg9‐bradykinin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrabrachial Lys‐[Leu8]‐des‐Arg9‐bradykinin (B1 antagonist)
Trial: 19033823
Drug: Bradykinin (B2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bradykinin (B2 agonist)
Trial: 12651680
Drug: Fentanyl (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (125 microg initial dose, testing interval 5 microg)
Trial: 9895070
Drug: TIVA/TCI (propofol-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIVA/TCI (propofol-based TCI system and continuous administration of remifentanil)
Trial: 9895070
Drug: Isoflurane (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflurane (inhaled anesthesia with isoflurane, fentanyl, and N2O)
Trial: 9895070
Drug: Standard propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard propofol (fentanyl and N2O with continuous infusion of propofol using a standard delivery system)
Trial: 8887038
Drug: High-dose intraperitoneal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intraperitoneal aprotinin treatment (aprotinin group, n = 22)
Trial: 1818424
Drug: IFN maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN maintenance therapy (3 x 10(6) I.U. INTRON‐A by subcutaneous injection three times a week for 4 months)
Trial: 7193447
Drug: Sequential administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential administration of methotrexate (50 mg/sq m orally) and cisplatin (intravenously 24 hours later), repeated four times at weekly intervals.
Trial: 7193447
Drug: Therapeutic postoperative
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic postoperative radiation therapy (for 43 patients operated on).
Trial: 26539650
Drug: simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: simvastatin 20 mg
Trial: 26539650
Drug: pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pravastatin 40 mg
Trial: 9777110
Drug: Diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 100 mg/day
Trial: 14998843
Drug: Single-agent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent chemotherapy
Trial: 25089351
Drug: Anti-VEGF treatment-naïve
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-VEGF treatment-naïve
Trial: 22348256
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate after 7 days washout (treatment C)
Trial: 22935621
Drug: 400-μg sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400-μg sublingual misoprostol
Trial: 16215602
Drug: Essential fatty
RxNorm normalized name: essential fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential fatty acids supplement for 8 weeks
Trial: 29460813
Drug: Placebo supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo supplement for 8 weeks
Trial: 12164090
Drug: Amlodipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (2 months treatment)
Trial: 12164090
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (intra-arterial infusion)
Trial: 12164090
Drug: Co-infusion of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-infusion of L-NMMA (inhibitor of nitric oxide synthase)
Trial: 9931520
Drug: Morphine (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (140 microg/kg over a 1-hour period followed by 20 microg/kg/hr)
Trial: 1968694
Drug: Alcuronium (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcuronium (0.03 mg/kg)
Trial: 619946
Drug: Tubocurarine (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tubocurarine (0.05 mg/kg)
Trial: 1968694
Drug: Vecuronium (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (0.01 mg/kg)
Trial: 27445072
Drug: Dorzolamide/timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide/timolol fixed combination (group A)
Trial: 27445072
Drug: Brinzolamide/brimonidine fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brinzolamide/brimonidine fixed combination (group B)
Trial: 26522035
Drug: Mini-implant anchored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini-implant anchored Forsus Fatigue Resistant Device (FMI)
Trial: 23377333
Drug: Scar product
RxNorm normalized name: Mederma Advanced Scar Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scar product (twice-daily application)
Trial: 17694726
Drug: Indiplon 10
RxNorm normalized name: Indiplon
DrugBank: Indiplon (DB12590)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indiplon 10 mg
Trial: 17694726
Drug: Indiplon 20
RxNorm normalized name: Indiplon
DrugBank: Indiplon (DB12590)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indiplon 20 mg
Trial: 1618258
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg
Trial: 30278560
Drug: Dexmedetomidine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1.0 μg/kg over 10 min) followed by maintenance (0.5 μg/kg/h)
Trial: 30278560
Drug: Midazolam (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.05 mg/kg) followed by dexmedetomidine maintenance (0.5 μg/kg/h)
Trial: 28393775
Drug: Sufentanil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (0.1 mcg/kg bolus followed by 0.1 mcg/h infusion)
Trial: 21613795
Drug: HD200 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD200 (200 mg/dl)
Trial: 21613795
Drug: HD100 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD100 (100 mg/dl)
Trial: 18362317
Drug: Removal in
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Removal in combination with a 'biological detoxification' therapy with high doses of vitamins and trace elements
Trial: 15000440
Drug: BCAA (14.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA (14.4 g/day)
Trial: 11061609
Drug: I-CHOPE regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-CHOPE regimen (doxorubicin 10 mg/m2/day, vincristine 0.28 mg/m2/day, etoposide 48 mg/m2/day, cyclophosphamide 750 mg/m2 on day 6, prednisone 100 mg/day on days 1-5)
Trial: 31838498
Drug: TTV loads
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTV loads ≥4log copies/ml in males
Trial: 25491929
Drug: 7 mg
RxNorm normalized name: pectin 7 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 mg nicotine patch
Trial: 17370487
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection at cervical Jiaji points and routine acupuncture
Trial: 12740311
Drug: Control (C)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (C) diet (meals providing carbohydrate (CHO) of 1.75 g/kg)
Trial: 8648356
Drug: Uft group
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uft group (1-year oral administration of UFT 400 mg/kg)
Trial: 22943608
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (surgical treatment only)
Trial: 6135989
Drug: Aspirin (324
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (324 mg in buffered solution daily for 12 weeks)
Trial: 3000793
Drug: Propranolol 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 240 mg
Trial: 27555178
Drug: Clonidine 1
RxNorm normalized name: apraclonidine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 μg/kg
Trial: 24875890
Drug: Dexmedetomidine 1
RxNorm normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1 μg/kg
Trial: 24121920
Drug: Intra-oral electrostimulator
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-oral electrostimulator (GenNarino)
Trial: 14705720
Drug: Enoxaparin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (40 mg subcutaneously once daily for 10 days)
Trial: 8976353
Drug: Vein Patch
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vein Patch Closure (SVP and JVP)
Trial: 8976353
Drug: Polytetrafluoroethylene Patch
RxNorm normalized name: polytetrafluoroethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polytetrafluoroethylene Patch Closure (PTFE‐PC)
Trial: 8976353
Drug: Vein Patch
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vein Patch Closure (JVP)
Trial: 1468239
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg etodolac SR once daily for 4 weeks
Trial: 1468239
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg diclofenac SR
Trial: 6478435
Drug: Multimodal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal therapy (2 courses of chemotherapy: cisplatin 2 mg/kg; methotrexate 280‐560 mg/m2 with leucovorin rescue; bleomycin 30 mu X 3) followed by radiation therapy and surgery
Trial: 9071898
Drug: Multimodal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal therapy
Trial: 6478435
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (preoperative radiation therapy followed by surgery)
Trial: 16019363
Drug: Continuous combined
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combined CEE/MPA 0.625 mg/day and 5 mg/day
Trial: 10485779
Drug: Ritonavir (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir (200 mg three times on the first day and 300 mg three times on the second day)
Trial: 8765815
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aqueous nasal spray (220 micrograms or 440 micrograms)
Trial: 31201146
Drug: Dimethicone (500
RxNorm normalized name: PEG-10 DIMETHICONE (500 CST)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimethicone (500 mg, three times a day for 2 weeks)
Trial: 31201146
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 mg, three times a day for 2 weeks)
Trial: 25197015
Drug: Conventional implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional implant placement
Trial: 19898698
Drug: Standard-dose simvastatin
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose simvastatin (20 mg/day to 40 mg/day)
Trial: 17123915
Drug: Fluoride-containing materials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride-containing materials (e.g., Fuji IX - FIX)
Trial: 12212341
Drug: Generic tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic tablets (Group B)
Trial: 9258217
Drug: Mitomycin, 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin, 0.2 mg/mL, applied for 2 minutes
Trial: 9258217
Drug: Mitomycin, 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin, 0.4 mg/mL, applied for 4 minutes
Trial: 9258217
Drug: Mitomycin, 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin, 0.4 mg/mL, applied for 2 minutes
Trial: 8438713
Drug: Excimer laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Excimer laser coronary angioplasty (ELCA) followed by adjunctive PTCA
Trial: 27009938
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy followed by Interval Debulking Surgery (NACT-IDS)
Trial: 25760680
Drug: GIK solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIK solution (insulin 0.1 IU kg(‐1) h(‐1) and an infusion of 30% dextrose and 80 mmol l(‐1) potassium at 0.5 ml kg(‐1) h(‐1))
Trial: 11696690
Drug: GIK solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIK solution
Trial: 19196892
Drug: Diuretic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic therapy
Trial: 7838644
Drug: LAT gel
RxNorm normalized name: Pleo lat whole
DrugBank: Bacillus cereus (DB19245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAT gel (4% lidocaine, 1:2000 adrenaline, 0.5% tetracaine)
Trial: 7838644
Drug: TAC gel
RxNorm normalized name: Zantac GELdose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAC gel (0.5% tetracaine, 1:2000 adrenaline, 11.8% cocaine)
Trial: 7838644
Drug: LAT gel
RxNorm normalized name: Pleo lat whole
DrugBank: Bacillus cereus (DB19245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAT gel
Trial: 7838644
Drug: TAC gel
RxNorm normalized name: Zantac GELdose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAC gel
Trial: 7838644
Drug: LAT gel
RxNorm normalized name: Pleo lat whole
DrugBank: Bacillus cereus (DB19245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAT gel and TAC gel
Trial: 699788
Drug: Propranolol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (3 x 40 mg/d or 3 x 80 mg/d)
Trial: 7261940
Drug: Propranolol treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol treatment
Trial: 23168366
Drug: Bevacizumab plus
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab plus chemotherapy (2.5 mg/kg per week equivalent, either 5 mg/kg every 2 weeks or 7.5 mg/kg every 3 weeks, intravenously)
Trial: 14673218
Drug: Trazodone CR
RxNorm normalized name: trazodone Extended Release Oral Tablet [Molipaxin CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone CR (150 mg)
Trial: 10807482
Drug: Right Unilateral
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Right Unilateral ECT (RUL ECT) at high dosage (150% or 500% above seizure threshold)
Trial: 10807482
Drug: Bilateral ECT
RxNorm normalized name: ECT-001 expanded cord blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral ECT (BL ECT) at high dosage (150% above seizure threshold)
Trial: 10807482
Drug: Low-dosage Unilateral
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dosage Unilateral ECT
Trial: 10807482
Drug: Moderate-dosage Unilateral
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dosage Unilateral ECT
Trial: 7695258
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg genaconazole intravenous infusion
Trial: 3234625
Drug: Synthetic salmon
RxNorm normalized name: Synthetic salmon calcitonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic salmon calcitonin (415 pmol bolus injection followed by infusion to reach an overall dose of 62.25 pmol.kg‐1 body mass)
Trial: 29290000
Drug: Fosfomycin tromethamine
RxNorm normalized name: FOSFOMYCIN TROMETHAMINE
DrugBank: Fosfomycin (DB00828)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin tromethamine (3 g, two oral doses)
Trial: 29290000
Drug: Standard-of-care antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-care antibiotic therapy (control group)
Trial: 14685040
Drug: Hyposensitization therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyposensitization therapy with Cry j 1 at doses of 0.01 microg/ml, 0.1 microg/ml, 1 microg/ml, and 10 microg/ml.
Trial: 14685040
Drug: Hyposensitization therapy.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyposensitization therapy.
Trial: 7942121
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro data at glucose concentrations > or = 13.8 mmol/L
Trial: 3496186
Drug: Enteric-coated fenoprofen
RxNorm normalized name: EC-0652
DrugBank: EC-0652 (DB15340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated fenoprofen calcium (600 mg q.i.d.)
Trial: 10811675
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg/m²
Trial: 8772621
Drug: Metformin (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (in overweight subgroup)
Trial: 30153782
Drug: High fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fluid group (≥ 3250 mL of fluid administered)
Trial: 9459253
Drug: Lidocaine 3
RxNorm normalized name: Lidocaine 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 3 mL (2%)
Trial: 318908
Drug: Meperidine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 40 mg
Trial: 7707111
Drug: Tamoxifen 10
RxNorm normalized name: tamoxifen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10 mg orally, twice daily for 3 months
Trial: 2496357
Drug: Aspirin-dipyridamole (990
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin-dipyridamole (990 mg/225 mg daily)
Trial: 580589
Drug: meproscillarin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meproscillarin (4 X 0.25 mg/d for 7 days)
Trial: 31253207
Drug: Propofol target-controlled
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol target-controlled infusion at 1.5 times C0
Trial: 31253207
Drug: Propofol target-controlled
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol target-controlled infusion at 2 times C0
Trial: 31253207
Drug: Propofol target-controlled
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol target-controlled infusion at 2.5 times C0
Trial: 21515482
Drug: Fluorouracil (PF)
RxNorm normalized name: FLUOROURACIL (PF) 50MG/ML INJ
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil (PF) regimen with concurrent radiotherapy
Trial: 8317719
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine infusion (0.5 mL saline bolus followed by 200 micrograms morphine infusion in 24 h)
Trial: 8317719
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine bolus (200 micrograms morphine as a single bolus followed by 3 mL saline infusion in 24 h)
Trial: 31570566
Drug: Telapristone acetate
RxNorm normalized name: Telapristone acetate
DrugBank: Telapristone acetate (DB05253)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telapristone acetate (TPA) 12 mg daily for 2 to 10 weeks
Trial: 25456710
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (exercise training + ventilation)
Trial: 21890575
Drug: STN‐DBS implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STN‐DBS implants
Trial: 20167117
Drug: Allopurinol 500
RxNorm normalized name: allopurinol 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 500 mg IV
Trial: 18056144
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release methylphenidate (Ritalin), administered three times a day
Trial: 335225
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication (control)
Trial: 15728647
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin treatment
Trial: 11206101
Drug: Trimetazidine IV
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine IV infusion started before PTCA and continued for 48 hours
Trial: 31631029
Drug: Cardiovascular medication
RxNorm normalized name: CARDIOVASCULAR MEDICATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiovascular medication use
Trial: 26833462
Drug: NNC0114‐0005 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC0114‐0005 (25 mg/kg)
Trial: 20975266
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of autologous CD34+ stem cells
Trial: 20975266
Drug: Intracoronary saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary saline injections (placebo control)
Trial: 6778345
Drug: PCP-8 (octavalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCP-8 (octavalent vaccine) administered at 25 micrograms of each serotype at 3-6 months and again at 18-24 months.
Trial: 6778345
Drug: PCP-7 or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCP-7 or PCP-8 administered to 44 infants followed for two years.
Trial: 28348190
Drug: Swallowing Intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Swallowing Intervention Package (SIP) delivered pre-treatment
Trial: 19806814
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of aprotinin (500,000 KIU, 50 mL)
Trial: 30110007
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (50 mL)